UBS Group AG - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 24 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$9,000
-25.0%
11,000
-15.4%
0.00%
Q1 2022$12,000
+9.1%
13,0000.0%0.00%
Q4 2021$11,000
-8.3%
13,0000.0%0.00%
Q3 2021$12,000
-7.7%
13,0000.0%0.00%
Q2 2021$13,000
+30.0%
13,000
+30.0%
0.00%
Q1 2021$10,00010,0000.00%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 157,390,000$141,877,0003.17%
Birch Grove Capital LP 8,000,000$7,200,0002.94%
PFM Health Sciences, LP 48,150,000$43,919,0001.64%
SILVERBACK ASSET MANAGEMENT LLC 8,505,000$7,665,0001.04%
DAFNA Capital Management LLC 1,500,000$1,345,0000.35%
DeepCurrents Investment Group LLC 8,696,000$7,756,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 11,092,000$10,005,0000.23%
ADVENT CAPITAL MANAGEMENT /DE/ 9,235,000$8,358,0000.13%
Verition Fund Management LLC 2,441,000$2,227,0000.03%
CAPSTONE INVESTMENT ADVISORS, LLC 6,000,000$5,473,0000.02%
View complete list of AERIE PHARMACEUTICALS INC shareholders